Interleukin-16 Promotes Cardiac Fibrosis and Myocardial Stiffening in Heart Failure With Preserved Ejection Fraction

PLoS ONE - United States
doi 10.1371/journal.pone.0068893
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Myocardial Injury and Cardiac Reserve Limitation in Heart Failure With Preserved Ejection Fraction

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2018English

Biomarkers, Myocardial Fibrosis and Co-Morbidities in Heart Failure With Preserved Ejection Fraction: An Overview

Archives of Medical Science
Medicine
2018English

Treating Heart Failure With Preserved Ejection Fraction: Learning From Pulmonary Fibrosis

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2018English

Cardiac Troponin and Outcome in Decompensated Heart Failure With Preserved Ejection Fraction

Cardiovascular Diagnosis and Therapy
Cardiovascular MedicineCardiology
2017English

Prognosis in Heart Failure With Preserved Ejection Fraction

sudan heart journal
2017English

Diffuse Right Ventricular Fibrosis in Heart Failure With Preserved Ejection Fraction and Pulmonary Hypertension

ESC heart failure
Cardiovascular MedicineCardiology
2020English

Microvascular Rarefaction and Heart Failure With Preserved Ejection Fraction

Frontiers in Cardiovascular Medicine
Cardiovascular MedicineCardiology
2019English

Spironolactone for Heart Failure With Preserved Ejection Fraction

New England Journal of Medicine
Medicine
2014English

Prognosis of Heart Failure With Stable Mid-Range Ejection Fraction in Comparison to Heart Failure With Stable Reduced Ejection Fraction and Heart Failure With Stable Preserved Ejection Fraction

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy